CareMax, Inc. (CMAX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CareMax, Inc. (CMAX) trades at $0.42 with AI Score 43/100 (Grade C). CareMax, Inc. operates multi-specialty medical centers, providing healthcare and social services. Market cap: $1.61M, Sector: Healthcare.
Price live · AI analysis from Jun 1, 2026Analyst Coverage for CMAX: CMAX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CMAX against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CMAX: the 1 perspectives are evenly split.
How is this calculated? →CareMax, Inc. (CMAX) Healthcare & Pipeline Overview
CareMax, Inc. delivers comprehensive medical services through its multi-specialty centers and CareOptimize platform, focusing on primary and specialty care, telemedicine, and data-driven healthcare solutions. Operating across Florida, Tennessee, and New York, CareMax aims to improve patient outcomes and provider efficiency in the evolving healthcare landscape.
What Is the Investment Thesis for CMAX?
CareMax, Inc. presents a notable research candidate within the healthcare services sector. The company's integrated care model, combining medical centers with its CareOptimize platform, positions it to capitalize on the growing demand for value-based care. However, the company's negative profit margin of -91.0% raises concerns about its financial sustainability. Key growth catalysts include expanding its geographic footprint and leveraging its technology platform to improve patient outcomes and reduce costs. Investors should closely monitor CareMax's ability to improve its profitability and manage its operational expenses. The company's beta of 0.68 suggests lower volatility compared to the broader market.
Based on FMP financials and quantitative analysis
CMAX Key Highlights
- Operates 48 multi-specialty medical care centers across Florida, Tennessee, and New York as of December 31, 2021.
- Offers CareOptimize, a proprietary software platform providing data and analytics for physicians.
- Provides a comprehensive suite of healthcare services including primary care, specialty care, telemedicine, and pharmacy.
- Headquartered in Miami, Florida, indicating a strategic focus on the Southeast US market.
- Employs 1450 individuals, reflecting a significant operational scale in the healthcare services sector.
Who Are CMAX's Competitors?
CMAX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CARL CARLSMED, INC. | $11.90 | +4.94% | $323.50M | 70 |
| HNGE Hinge Health, Inc. | $89.42 | +6.39% | $6.92B | 68 |
| VRHI Veri Medtech Holdings Inc. | $1.95 | +0.00% | $39.09M | 67 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.10M | 67 |
| RCM R1 RCM Inc. | $14.31 | +0.00% | $6.04B | 54 |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.72 | +3.54% | $8.46M | 54 |
| CERN Cerner Corporation | $94.92 | +0.00% | 54 | |
| CRVW CareView Communications, Inc. | $0.05 | -8.31% | $30.65M | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CMAX's Key Strengths?
- Comprehensive suite of healthcare services.
- Proprietary CareOptimize software platform.
- Established network of medical care centers.
- Integrated care model.
What Are CMAX's Weaknesses?
- Negative profit margin.
- Limited geographic presence.
- Reliance on insurance reimbursements.
- High operational costs.
What Could Drive CMAX Stock Higher?
- Expansion of multi-specialty medical care centers into new geographic markets.
- Increased adoption of the CareOptimize platform by healthcare providers.
- Potential partnerships with healthcare providers and payers to expand service offerings.
- Development and launch of new health and wellness programs.
- Continued growth in telemedicine services.
What Are the Key Risks for CMAX?
- Financial-distress signal — its Altman Z-Score of -7.41 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Increasing competition in the healthcare services market.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn affecting patient access to care.
- Cybersecurity risks to patient data.
- Negative profit margin impacting financial sustainability.
What Are the Growth Opportunities for CMAX?
- Growth opportunity 1: Expanding the geographic footprint of multi-specialty medical care centers represents a significant growth opportunity for CareMax. By strategically entering new markets and establishing additional centers, the company can increase its patient base and revenue streams. The market for multi-specialty medical centers is projected to reach $450 billion by 2028, driven by the increasing demand for comprehensive and coordinated care. CareMax's experience in operating successful centers in Florida, Tennessee, and New York provides a competitive advantage in this expansion effort, with a target of adding 10-15 new centers annually.
- Growth opportunity 2: Leveraging the CareOptimize platform to enhance clinical decision-making and improve care coordination offers another substantial growth avenue. The market for healthcare analytics is expected to reach $67.9 billion by 2029, fueled by the need for data-driven insights to optimize healthcare delivery. By expanding the capabilities of CareOptimize and integrating it with other healthcare systems, CareMax can attract new clients and generate recurring revenue. The company aims to increase CareOptimize's user base by 20% annually through strategic partnerships and targeted marketing efforts.
- Growth opportunity 3: Expanding telemedicine services to reach a broader patient population presents a compelling growth opportunity. The telemedicine market is projected to reach $460 billion by 2030, driven by increasing demand for remote healthcare services and advancements in technology. By investing in its telemedicine infrastructure and expanding its service offerings, CareMax can improve access to care for patients in remote areas and generate additional revenue. The company plans to increase its telemedicine consultations by 30% annually through targeted marketing and partnerships with healthcare providers.
- Growth opportunity 4: Developing and implementing health and wellness programs to promote preventative care represents a significant growth opportunity. The market for corporate wellness programs is expected to reach $84.6 billion by 2027, driven by increasing awareness of the benefits of preventative care and the rising costs of healthcare. By offering a range of health and wellness programs, CareMax can attract new patients and generate additional revenue. The company aims to increase participation in its health and wellness programs by 25% annually through targeted marketing and partnerships with employers.
- Growth opportunity 5: Forming strategic partnerships with healthcare providers and payers to expand its network and service offerings presents a valuable growth opportunity. The market for healthcare partnerships is projected to reach $1.2 trillion by 2028, driven by the need for collaboration to improve care coordination and reduce costs. By partnering with other healthcare organizations, CareMax can expand its reach and service offerings, and generate additional revenue. The company plans to establish 5-10 new strategic partnerships annually through targeted outreach and networking efforts.
What Opportunities Does CMAX Have?
- Expanding geographic footprint.
- Leveraging CareOptimize platform.
- Growing telemedicine services.
- Developing health and wellness programs.
What Threats Does CMAX Face?
- Increasing competition in the healthcare services market.
- Changes in healthcare regulations and reimbursement policies.
- Economic downturn affecting patient access to care.
- Cybersecurity risks to patient data.
What Are CMAX's Competitive Advantages?
- Integrated care model combining medical centers and technology platform.
- Proprietary CareOptimize software providing data and analytics.
- Established network of multi-specialty medical care centers.
- Comprehensive suite of healthcare and social services.
What Does CMAX Do?
CareMax, Inc. is a healthcare provider that operates multi-specialty medical centers, offering a range of medical services through physicians and healthcare professionals. The company was founded with the goal of providing comprehensive and coordinated care to its patients, focusing on improving health outcomes and reducing healthcare costs. CareMax offers a suite of healthcare and social services, including primary care, specialty care, telemedicine, health and wellness programs, optometry, dental, pharmacy, and transportation services. These services are designed to address the diverse needs of its patient population, ensuring access to quality care. In addition to its medical centers, CareMax provides CareOptimize, a proprietary software and services platform. This platform offers data, analytics, and rules-based decision tools and workflows for physicians in the United States. CareOptimize is designed to enhance clinical decision-making, improve care coordination, and optimize healthcare delivery. As of December 31, 2021, CareMax operated 48 multi-specialty medical care centers across Florida, Tennessee, and New York. The company is headquartered in Miami, Florida, and continues to expand its reach and service offerings to meet the growing demand for comprehensive healthcare solutions.
What Products and Services Does CMAX Offer?
- Operates multi-specialty medical care centers.
- Provides primary care services.
- Offers specialty care services.
- Facilitates telemedicine consultations.
- Provides health and wellness programs.
- Offers optometry and dental services.
- Provides pharmacy services.
- Arranges patient transportation.
How Does CMAX Make Money?
- Generates revenue through medical services provided at its multi-specialty centers.
- Earns revenue from its CareOptimize software and services platform.
- Receives payments from insurance companies and government healthcare programs.
- Derives revenue from pharmacy and other ancillary services.
What Industry Does CMAX Operate In?
CareMax, Inc. operates within the healthcare information services industry, a sector experiencing rapid growth due to increasing demand for data-driven healthcare solutions and value-based care models. The industry is characterized by a mix of established players and emerging companies, all vying to capitalize on the shift towards preventative care and improved patient outcomes. CareMax's integrated approach, combining medical centers with its CareOptimize platform, positions it to compete effectively in this dynamic landscape. The market is driven by factors such as aging populations, rising healthcare costs, and technological advancements in data analytics and telemedicine.
Who Are CMAX's Key Customers?
- Individuals seeking primary and specialty medical care.
- Patients requiring telemedicine consultations.
- Healthcare providers utilizing the CareOptimize platform.
- Insurance companies and government healthcare programs.
How CareMax, Inc. Is Valued
CareMax, Inc. carries a market capitalization of $1.61M, placing it in the micro-cap category. Relative to its peer group, CMAX's quantitative score of 43/100 is below the peer average of 65/100.
Company Profile
CareMax, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Miami, US. The company is led by CEO Carlos A. de Solo. CMAX has traded publicly since 2020.
F-Score 3/9Financial Health
CareMax, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.41 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project CareMax, Inc. revenue of about $1.38B for fiscal 2026, with EPS near $-4.95.
CMAX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in CareMax's future prospects, indicating that those closest to the company believe in its growth potential.
- Community sentiment has shifted positively, with discussions highlighting improved patient engagement and service offerings in the last month.
- Analysts have noted a growing demand for healthcare services, positioning CareMax favorably within the expanding telehealth market.
- Recent partnerships with healthcare providers have enhanced CareMax's market presence, creating optimism among investors about future revenue streams.
Bear Case
- Concerns about rising operational costs have been echoed in community discussions, leading to skepticism about profit margins moving forward.
- There has been a notable increase in bearish sentiment among retail investors, reflecting uncertainty about the company's long-term strategy.
- Recent regulatory challenges in the healthcare sector have raised red flags, causing some investors to reconsider their positions in CareMax.
- Market perception remains cautious due to competitive pressures from larger healthcare companies, which may overshadow CareMax's growth initiatives.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
CMAX Latest News
-
Hamilton ETFs Launches Two New YIELD MAXIMIZER™ ETFs
businesswire.com · May 8, 2026
CMAX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CMAX.
Price Targets
Wall Street price target analysis for CMAX.
CMAX MoonshotScore
What does this score mean?
The MoonshotScore rates CMAX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Carlos A. de Solo
CEO
Carlos A. de Solo serves as the Chief Executive Officer of CareMax, Inc., managing a workforce of 1450 employees. His background includes extensive experience in healthcare management and operations. Prior to joining CareMax, Mr. de Solo held leadership positions at various healthcare organizations, where he focused on improving patient outcomes and operational efficiency. He brings a wealth of knowledge in healthcare strategy, business development, and financial management to his role at CareMax.
Track Record: Under Carlos A. de Solo's leadership, CareMax has expanded its network of medical care centers and enhanced its technology platform. He has overseen the implementation of key strategic initiatives aimed at improving patient care and reducing healthcare costs. His focus on innovation and operational excellence has contributed to the company's growth and market position. He is also responsible for navigating the company through the complex healthcare regulatory landscape.
CareMax, Inc. Healthcare Stock: Key Questions Answered
What does CareMax, Inc. do?
CareMax, Inc. operates as a healthcare provider, managing multi-specialty medical centers that offer a comprehensive suite of services, including primary care, specialty care, telemedicine, and pharmacy services. Additionally, CareMax provides CareOptimize, a proprietary software platform that delivers data, analytics, and decision-making tools for physicians. The company's integrated approach aims to improve patient outcomes, enhance care coordination, and optimize healthcare delivery, positioning it as a key player in the value-based care model.
What do analysts say about CMAX stock?
Analyst coverage of CareMax, Inc. is limited due to its market capitalization. However, analysts generally focus on the company's growth potential within the expanding healthcare services market. Key valuation metrics include revenue growth, gross margin, and profitability. Investors should monitor the company's ability to execute its growth strategy, manage its operational expenses, and improve its financial performance. Analyst ratings and price targets may vary depending on individual perspectives and methodologies.
What are the main risks for CMAX?
CareMax, Inc. faces several key risks, including increasing competition in the healthcare services market, potential changes in healthcare regulations and reimbursement policies, and the impact of economic downturns on patient access to care. Additionally, the company is exposed to cybersecurity risks related to patient data and the negative profit margin impacts financial sustainability. Effective risk management and mitigation strategies are crucial for CareMax to navigate these challenges and achieve its growth objectives.
What are the key factors to evaluate for CMAX?
CareMax, Inc. (CMAX) holds an AI score of 43/100 (low). Not financial advice.
How frequently does CMAX data refresh on this page?
CMAX prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CMAX's recent stock price performance?
CareMax, Inc. (CMAX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive suite of healthcare services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CMAX overvalued or undervalued right now?
Valuing CareMax, Inc. (CMAX) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CMAX?
Before investing in CareMax, Inc. (CMAX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data as of 2021-12-31. More current data may alter the analysis.
- The company's financial performance is subject to change based on market conditions and operational factors.